NCT00664469 - INdians Followed for INtensive Lipid Lowering Treatment and Its safetY | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

November 30, 2010

Conditions

Hypercholesterolemia

Interventions

DRUG

ezetimibe

ezetimibe 10 mg/day over a 6-week course of treatment.

DRUG

Comparator: Simvastatin 20, 40 and 80 mg

Simvastatin 20, 40 and 80 mg; actual statin regimen for 6 weeks followed by another 6 weeks if at goal or statin dose can be doubled.

DRUG

Comparator: Atorvastatin

Atorvastatin 20, 40 \& 80 mg; actual statin regimen for 6 weeks followed by another 6 weeks if at goal or statin dose can be doubled.

DRUG

Comparator: Rosuvastatin

Rosuvastatin 10, 20 \& 40 mg; actual statin regimen for 6 weeks followed by another 6 weeks if at goal or statin dose can be doubled.

Trial Locations (1)

Merck Frosst Canada Ltd., Kirkland